Correlation Between LB Pharmaceuticals and Contineum Therapeutics,
Can any of the company-specific risk be diversified away by investing in both LB Pharmaceuticals and Contineum Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LB Pharmaceuticals and Contineum Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LB Pharmaceuticals Common and Contineum Therapeutics, Class, you can compare the effects of market volatilities on LB Pharmaceuticals and Contineum Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LB Pharmaceuticals with a short position of Contineum Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of LB Pharmaceuticals and Contineum Therapeutics,.
Diversification Opportunities for LB Pharmaceuticals and Contineum Therapeutics,
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between LBRX and Contineum is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding LB Pharmaceuticals Common and Contineum Therapeutics, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Contineum Therapeutics, and LB Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LB Pharmaceuticals Common are associated (or correlated) with Contineum Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Contineum Therapeutics, has no effect on the direction of LB Pharmaceuticals i.e., LB Pharmaceuticals and Contineum Therapeutics, go up and down completely randomly.
Pair Corralation between LB Pharmaceuticals and Contineum Therapeutics,
Given the investment horizon of 90 days LB Pharmaceuticals Common is expected to under-perform the Contineum Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, LB Pharmaceuticals Common is 1.45 times less risky than Contineum Therapeutics,. The stock trades about -0.04 of its potential returns per unit of risk. The Contineum Therapeutics, Class is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 580.00 in Contineum Therapeutics, Class on August 4, 2025 and sell it today you would earn a total of 521.00 from holding Contineum Therapeutics, Class or generate 89.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 58.46% |
| Values | Daily Returns |
LB Pharmaceuticals Common vs. Contineum Therapeutics, Class
Performance |
| Timeline |
| LB Pharmaceuticals Common |
| Contineum Therapeutics, |
LB Pharmaceuticals and Contineum Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LB Pharmaceuticals and Contineum Therapeutics,
The main advantage of trading using opposite LB Pharmaceuticals and Contineum Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LB Pharmaceuticals position performs unexpectedly, Contineum Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Contineum Therapeutics, will offset losses from the drop in Contineum Therapeutics,'s long position.| LB Pharmaceuticals vs. Replimune Group | LB Pharmaceuticals vs. Altimmune | LB Pharmaceuticals vs. Larimar Therapeutics | LB Pharmaceuticals vs. Tenaya Therapeutics |
| Contineum Therapeutics, vs. Aldeyra | Contineum Therapeutics, vs. Vanda Pharmaceuticals | Contineum Therapeutics, vs. Annexon | Contineum Therapeutics, vs. Galectin Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets |